Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

Items 501–600 of 998

Posttraumatic Stress Disorder Symptoms and Social and Occupational Functioning of People With Schizophrenia
Ng, L. C., Petruzzi, L. J., Greene, M. C., Mueser, K. T., Borba, C. P. C., & Henderson, D. C. (2016) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000523 · Cited by 17
Perspectives on the Positive and Negative Syndrome Scale (Panss): Use, Misuse, Drawbacks, and A New Alternative for Schizophrenia Research
Aboraya, A., & Nasrallah, H. A. (2016) · Annals of Clinical Psychiatry · doi:10.1177/104012371602800206 · Cited by 46
What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study
Johansson, M., Hjärthag, F., & Helldin, L. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.007 · Cited by 17
Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity
Berendsen, S., van der Veen, N. M., van Tricht, M. J., & de Haan, L. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.059 · Cited by 17
Patterns and Correlates of Expressed Emotion, Perceived Criticism, and Rearing Style in First Admitted Early-Onset Schizophrenia Spectrum Disorders
von Polier, G. G., Meng, H., Lambert, M., Strauss, M., Zarotti, G., Karle, M., Dubois, R., Stark, F.-M., Neidhart, S., Zollinger, R., et al. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000209 · Cited by 17
Olanzapine orally disintegrating tablets (Zyprexa ZydisR) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study
Hori, H., Ueda, N., Yoshimura, R., Yamamoto, H., Wani, K., Etoh, Y., Haraga, K., Kitahara, J., & Nakamura, J. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903166312 · Cited by 17
Experience of quality of life and attitude to care and treatment in patients with schizophrenia: Role of cross-sectional remission
Helldin, L., Kane, J. M., Karilampi, U., Norlander, T., & Archer, T. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500701660007 · Cited by 17
The effect of transcranial direct current stimulation on psychotic symptoms of schizophrenia is associated with oxy-hemoglobin concentrations in the brain as measured by near-infrared spectroscopy: A pilot study
Narita, Z. C., Noda, T., Setoyama, S., Sueyoshi, K., Inagawa, T., & Sumiyoshi, T. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.004 · Cited by 17
Ethical Reflections on Offering Patients Accelerated Resolution Therapy (ART).
Ivanova, E., Khan, A., Liharska, L., Reznik, A. M., Kuzmin, S., Kushnir, O., Агарков, А. П., Bokhan, N. A., Pogorelova, T., Khomenko, O., et al. (2018) · Europe PMC (PubMed Central) · Cited by 17
Inteurleukin-8 gene variations and the susceptibility to schizophrenia
Afia, A. B., Aflouk, Y., Saoud, H., Zaafrane, F., Gaha, L., & Jrad, B. B. H. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113421 · Cited by 17
Effects of mild‐intensity physical exercise on neurocognition in inpatients with schizophrenia: A pilot randomized controlled trial
Kurebayashi, Y., Mori, K., & Otaki, J. (2021) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12896 · Cited by 19
Individuals at ultra-high risk of psychosis and first-degree relatives of patients with schizophreniaexperience impaired family functionality and social support deficit in comparison to healthy controls
He, X., Hou, C., Huang, Z., Huang, Y., Zhang, J.-J., Wang, Z., & Jia, F. (2021) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2021.152263 · Cited by 17
Muay Thai, Psychological Well-Being, and Cultivation of Combat-Relevant Affordances
Croom, A. M. (2022) · Philosophies · doi:10.3390/philosophies7030065 · Cited by 17
Transcranial Direct Current Stimulation on the Left Superior Temporal Sulcus Improves Social Cognition in Schizophrenia: An Open-Label Study
Yamada, Y., Sueyoshi, K., Yokoi, Y., Inagawa, T., Hirabayashi, N., Oi, H., Shirama, A., & Sumiyoshi, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.862814 · Cited by 17
Power and Perceived Expressed Emotion of Voices: Their Impact on Depression and Suicidal Thinking in Those Who Hear Voices
Connor, C., & Birchwood, M. J. (2011) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.798 · Cited by 17
Duration of untreated psychosis and acute remission of negative symptoms in a S outh A merican first‐episode psychosis cohort
González‐Valderrama, A., Castañeda, C. P., Mena, C., Undurraga, J. P., Mondaca, P., Yañez, M., Bedregal, P., & Nachar, R. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12266 · Cited by 17
PSYCHOMETRIC PROPERTIES OF THE BURDEN INVENTORY FOR RELATIVES OF PERSONS WITH PSYCHOTIC DISTURBANCES
Hjärthag, F., Helldin, L., & Norlander, T. (2008) · Psychological Reports · doi:10.2466/pr0.103.2.323-335 · Cited by 17
Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong
Yeung, F. K. C., & Chan, S. H. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0006-z · Cited by 17
Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.
Aich, T. K., Sinha, V. K., Khess, C. R. J., & Singh, S. (2004) · PubMed Central · Cited by 17
Multivantaged assessment of depression in schizophrenia
Lindenmayer, J., Kay, S. R., & Plutchik, R. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90112-g · Cited by 17
Effects of Olanzapine on Lipid Abnormalities in Elderly Psychotic Patients
Barak, Y., & Aizenberg, D. (2003) · Drugs & Aging · doi:10.2165/00002512-200320120-00003 · Cited by 17
Interrelations between psychiatric symptoms and drug-induced movement disorder
Chouinard, G. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0621 · Cited by 16
Evaluation of auditory hallucinations in patients with schizophrenia: A validation study of the Malay version of Psychotic Symptom Rating Scales (PSYRATS)
Wahab, S. B., Zakaria, M. N., Sidek, D., Rahman, A. H. A., Shah, S. A., & Wahab, N. A. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.014 · Cited by 16
Predictors and mediators of trait anger across the psychosis continuum: The role of attachment style, paranoia and social cognition
Darrell-Berry, H., Bucci, S., Palmier‐Claus, J. E., Emsley, R., Drake, R., & Berry, K. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.007 · Cited by 19
Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids
Huang, Y., Hung, C., Lin, P., Lee, Y., Wu, C., Hsu, S., Chen, C.-C., Chong, M., Lin, C., & Wang, L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.06.017 · Cited by 17
Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication
Kruiper, C., Glenthoj, B. Y., & Oranje, B. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0351-6 · Cited by 16
Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study
Fountoulakis, K. Ν., Dragioti, E., Antonis, T., Wiklund, T., Atmatzidis, X., Nimatoudis, I., Thys, E., Wampers, M., Hranov, L. G., Hristova, T., et al. (2020) · CNS Spectrums · doi:10.1017/s1092852920001091 · Cited by 16
Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction
Rajji, T. K., Mamo, D. C., Holden, J. L., Granholm, E. L., & Mulsant, B. H. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.051 · Cited by 18
Monocyte chemoattractant protein-1 promoter –2518 polymorphism and schizophrenia in the Korean population
Pae, C., Chung, K.-I., Kim, J.-J., Yu, H.-S., Lee, C., Lee, S.-J., Lee, C., Jun, T., Serretti, A., & Paik, I. (2004) · Psychiatric Genetics · doi:10.1097/01.ypg.0000128764.07344.06 · Cited by 16
“Everyone Needs a Friend Sometimes” – Social Predictors of Long-Term Remission In First Episode Psychosis
Bjørnestad, J. R., Joa, I., Larsen, T. K., Langeveld, J., Davidson, L., Hegelstad, W. T. V., Anda, L. G., Veseth, M., Melle, I. S., Johannessen, J. O., et al. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01491 · Cited by 17
Decreased value-sensitivity in schizophrenia
Martinelli, C., Rigoli, F., Dolan, R. J., & Shergill, S. S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.10.031 · Cited by 16
Association Studies of HSPA1A and HSPA1L Gene Polymorphisms With Schizophrenia
Kowalczyk, M., Kucia, K. A., Owczarek, A. J., Suchanek-Raif, R., Merk, W., Paul-Samojedny, M., & Kowalski, J. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.002 · Cited by 16
Combined clozapine-lithium treatment for schizophrenia and schizoaffective disorder
Moldavsky, M., Stein, D. J., Benatov, R., Sirota, P., Elizur, A., Matzner, Y., & Weizman, A. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80027-8 · Cited by 16
ADHERENCE AND NONADHERENCE TO ANTIPSYCHOTIC MEDICATIONS
Kozuki, Y., & Schepp, K. G. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840590922425 · Cited by 16
Validation of the Computerized Suicide Risk Scale – a backpropagation neural network instrument (CSRS-BP)
Modai, I., Ritsner, M., Kurs, R., Mendel, S., & Ponizovsky, A. M. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00631-4 · Cited by 16
Visual Feedback Therapy to Enhance Medication Adherence in Psychosis
Kozuki, Y., Poupore, E., & Schepp, K. G. (2005) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2005.02.008 · Cited by 16
Psychotic Continuum or Distinct Entities: Perspective from Psychopharmacology
Meltzer, H. Y. (1995) · Springer eBooks · doi:10.1007/978-3-642-79485-8_4 · Cited by 16
Self-defining memories predict engagement in structured activity in first episode psychosis, independent of neurocognition and metacognition
Wright, A. C., Davies, G., Fowler, D., & Greenwood, K. E. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby155 · Cited by 15
A new sex-specific underlying mechanism for female schizophrenia: accelerated skewed X chromosome inactivation
Zhang, X., Li, Y., Ma, L., Zhang, G., Liu, M., Wang, C., Zheng, Y., & Li, R. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00315-6 · Cited by 15
The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
Krzyściak, W., Karcz, P., Bystrowska, B., Szwajca, M., Bryll, A., Śmierciak, N., Ligezka, A. N., Turek, A., Kozicz, T., Skalniak, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020240 · Cited by 15
Association of HSPA1B Polymorphisms with Paranoid Schizophrenia in a Polish Population
Kowalczyk, M., Kucia, K. A., Owczarek, A. J., Suchanek-Raif, R., Merk, W., Fila-Daniłow, A., Paul-Samojedny, M., Choręza, P. S., & Kowalski, J. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08575-1 · Cited by 16
Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells
Powell, S. K., O’Shea, C. P., Shannon, S. R., Akbarian, S., & Brennand, K. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_6 · Cited by 16
Relationship of Change in Plasma Clozapine/N-desmethylclozapine Ratio with Cognitive Performance in Patients with Schizophrenia
Park, R., Kim, S., & Kim, E. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0306 · Cited by 15
A prospective study to explore the relationship between MTHFR C677T genotype, physiological folate levels, and postpartum psychopathology in at-risk women
Morris, E. M., Hippman, C., Albert, A., Slomp, C., Inglis, A. J., Carrion, P. B., Batallones, R., Andrighetti, H. J., Ross, C. J., Dyer, R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243936 · Cited by 17
Réintroduction de la clozapine chez les patients souffrant de schizophrénie résistante « super répondeurs », après neutropénie sous clozapine : à propos d’un cas
Huguet, G., Louët, A. L., Darnige, L., Lôo, H., & Krebs, M. (2013) · L Encéphale · doi:10.1016/j.encep.2013.02.003 · Cited by 15
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders
Schennach-Wolff, R., Seemüller, F., Obermeier, M., Messer, T., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., Klosterkötter, J., et al. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.11.005 · Cited by 15
Evaluation of the impact of a psycho-educational intervention on knowledge levels and psychological outcomes for people diagnosed with Schizophrenia and their caregivers in Jordan: a randomized controlled trial
Hasan, A. A., Callaghan, P., & Lymn, J. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-17 · Cited by 15
Evaluation of the Use of the Positive and Negative Syndrome Scale-Excited Component as a Criterion for Administration of P.R.N. Medication
Chaichan, W. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000314317.79544.b4 · Cited by 15
Drug Class Review: Atypical Antipsychotic Drugs
McDonagh, M. S., Peterson, K., Carson, S., Fu, R., & Thakurta, S. (2010) · Cited by 14
A three-year naturalistic follow-up of patients receiving clozapine: Report from India
Srivastava, S., Agarwal, A., & Sharma, M. (2002) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/136515002760276108 · Cited by 15
A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia
Arango, C., Gómez-Beneyto, M., Brenlla, J., Gastó, C., Sarramea-Crespo, F., Chamorro, L., Masramon, X., & Díez, T. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.11.007 · Cited by 15
Does the presenilin 2 gene predispose to schizophrenia?
Zhang, J., Chen, J., Xu, Q., & Shen, Y. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.013 · Cited by 14
An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia
Kumar, S., Mulsant, B. H., Tsoutsoulas, C., Ghazala, Z., Voineskos, A. N., Bowie, C. R., & Rajji, T. K. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4547 · Cited by 14
Physical Activity, Sleep-related Behaviors and Severity of Symptoms in Schizophrenia
Taliercio, J. R., Bonasera, B., Portillo, C., Ramjas, E., & Serper, M. R. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113489 · Cited by 15
Cyproheptadine for Prevention of Neuropsychiatric Adverse Effects of Efavirenz: A Randomized Clinical Trial
Dabaghzadeh, F., Ghaeli, P., Khalili, H., Alimadadi, A., Jafari, S., Akhondzadeh, S., & Khazaeipour, Z. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0410 · Cited by 14
Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T
Li, Y., Lui, S., Deng, W., Wu, M. C., Chen, L., Xiao, Y., Lama, S., Zhang, W., Huang, X., Li, T., et al. (2013) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-013-0411-6 · Cited by 14
Older Patients With Schizophrenia: Does Military Veteran Status Matter?
Thorp, S. R., Sones, H. M., Glorioso, D., Thompson, W., Light, G. A., Golshan, S., & Jeste, D. V. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182096ae5 · Cited by 14
Path models of Quality of Life among People with Schizophrenia Living in the Community in Hong Kong
Chan, S. H., & Yeung, F. K. C. (2007) · Community Mental Health Journal · doi:10.1007/s10597-007-9114-7 · Cited by 14
Carbon dioxide induction of panic anxiety in schizophrenia with auditory hallucinations
Savitz, A. J., Kahn, T. A., McGovern, K. E., & Kahn, J. P. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.06.008 · Cited by 14
Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis
Wijnen, B. F. M., Pos, K., Velthorst, E., Schirmbeck, F. N., Chan, H. Y., de Haan, L., van der Gaag, M., Evers, S., & Smit, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206236 · Cited by 14
Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method
Randau, M., Oranje, B., Miyakoshi, M., Makeig, S., Fagerlund, B., Glenthoj, B. Y., & Bak, N. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101760 · Cited by 14
Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: AnOpen-Label, Randomized, Study Versus Haloperidol
de Oliveira, I. R., Elkis, H., Gattaz, W. F., Chaves, A. C., de Sena, E. P., Souza, F. G. D. M. E., Campos, J. A. D. O., Bueno, J. R., Silva, J. A. C. E., Louzã, M. R., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900000249 · Cited by 14
Alternative methods to evaluate trial level surrogacy
Abrahantes, J. C., Shkedy, Z., & Molenberghs, G. (2008) · Clinical Trials · doi:10.1177/1740774508091677 · Cited by 14
One Year Follow-up of Patients with Bipolar Disorder Admitted to Roozbeh Hospital
Amini‎, H., Sharifi‎, V., Safa, A. A. N., Mohammad, A., Tabatabaei, M., علیمددی, ز., Hosseini, F. F., Milajerdi, M., Manouchehri, A., & Sedigh, A. (2009) · Iranian Journal of Psychiatry and Clinical Psychology · Cited by 14
Stress sensitivity in paranoia: poor-me paranoia protects against the unpleasant effects of social stress
Udachina, A., Bentall, R. P., Varese, F., & Rowse, G. (2017) · Psychological Medicine · doi:10.1017/s0033291717001362 · Cited by 14
Delayed habituation of the skin-conductance orienting response correlates with impaired performance on the wisconsin card sorting task in schizophrenia
Schiffer, R., Sigal, M., & Mintz, M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02845-4 · Cited by 14
Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients
Whelton, C., Gupta, R. N., Cleghorn, J. M., & Balagh, S. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90035-h · Cited by 14
Symptom Severity and Personal Functioning Among Patients with Schizophrenia Discharged from Long-Term Hospital Care into the Community
Trauer, T. (2001) · Community Mental Health Journal · doi:10.1023/a:1002761732040 · Cited by 14
An approach to treatment resistance in schizophrenia
Marder, S. R. (1999) · The British Journal of Psychiatry · doi:10.1192/s0007125000293616 · Cited by 14
Acceptance and Commitment Therapy for depression following psychosis: An examination of clinically significant change
White, R. G., Gumley, A. I., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., McLeod, H. J., & Mitchell, G. (2015) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2015.06.004 · Cited by 13
Mechanisms of action and processes of yoga-based group intervention for inpatients with schizophrenia spectrum disorders–A longitudinal qualitative study
Töbelmann, L., Hahne, I., Schulze, T., Bergmann, N., Fuchs, L., Zierhut, M., Hahn, E., & Böge, K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1086468 · Cited by 13
“The PANSS displays a good internal consistency, good interrater reliability, and construct validity (75, 76).”
Background
Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry
Huang, T., Lo, L., Shiea, J., & Su, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.011 · Cited by 13
Differentiating people with schizophrenia from healthy controls in a developing Country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool
Tran, B. X., Nguyen, T. T., Boyer, L., Fond, G. B., Auquier, P., Nguyen, H. S. A., Tran, H. T. N., Nguyen, H. M., Choi, J., Le, H. T., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1061284 · Cited by 13
Lifestyle intervention based on exercise and behavioural counselling and its effect on physical and psychological health in outpatients with schizophrenia spectrum disorders. An exploratory, pragmatic randomized clinical trial
Fernández-Abascal, B., Suárez‐Pinilla, M., Cobo-Corrales, C., Crespo‐Facorro, B., & Suárez‐Pinilla, P. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.09.036 · Cited by 14
Effectiveness of lifestyle intervention on prevention/management of antipsychotic-induced weight gain among persons with severe mental illness: A systematic review and meta-analysis
Mohanty, K., Gandhi, S., Prasad, M. K., John, A. P., Bhaskarapillai, B., Malo, P. K., & Thirthalli, J. (2024) · Journal of Health Psychology · doi:10.1177/13591053241227384 · Cited by 13
Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome
Dong, Y., Zhu, M., Li, Y., Liu, N., Wang, X., Yang, B., Li, S., & Li, Z. (2024) · Schizophrenia · doi:10.1038/s41537-024-00469-x · Cited by 13
Should early improvement be re‐defined to better predict the maintenance of response in first‐episode schizophrenia patients?
Schennach, R., Riesbeck, M., Mayr, A. J., Seemüller, F., Maier, W., Klingberg, S., Heuser, I., Klosterkötter, J., Gastpar, M., Schmitt, A., et al. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12006 · Cited by 13
Marginal Correlation in Longitudinal Binary Data Based on Generalized Linear Mixed Models
Vangeneugden, T., Molenberghs, G., Laenen, A., Geys, H., Beunckens, C., & Sotto, C. (2010) · Communication in Statistics- Theory and Methods · doi:10.1080/03610920903249568 · Cited by 13
Reduced white matter integrity and facial emotion perception in never-medicated patients with first-episode schizophrenia: A diffusion tensor imaging study
Zhao, X., Sui, Y., Yao, J., Lv, Y., Zhang, X., Jin, Z., Chen, L., & Zhang, X. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.025 · Cited by 13
Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
Huang, Y., Lin, P., Lee, Y., Hung, C., Hsu, S., Wu, C., & Wang, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s157055 · Cited by 13
Medial temporal lobe cortical changes in response to exercise interventions in people with early psychosis: A randomized controlled trial
Woodward, M. L., Lin, J., Gicas, K. M., Su, W., Hui, C. L. M., Honer, W. G., Chen, E. Y. H., & Lang, D. J. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.043 · Cited by 13
Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients
le Sommer, J., Low, A.-M., Jepsen, J. R. M., Fagerlund, B., Vangkilde, S., Habekost, T., Glenthoj, B. Y., & Oranje, B. (2021) · Psychological Medicine · doi:10.1017/s0033291721002373 · Cited by 13
Pharmacist‐Designed and ‐Implemented Pharmaceutical Care Plan for Antipsychotic‐Induced Movement Disorders
Stoner, S. C., Worrel, J. A., Jones, M. T., Farrar, C. D., & Ramlatchman, L. V. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.6.583.35159 · Cited by 13
The Relationship between Obsessions and Compulsions and Negative and Positive Symptoms in Schizophrenia.
Nasrollahi, N., Bigdelli, I., Mohammadi, M. R., & Hosseini, S. M. (2012) · PubMed Central · Cited by 13
Impairments in Negative Facial Emotion Recognition in Chinese Schizophrenia Patients Detected With a Newly Designed Task
Song, Y., Xiang, Y., Huang, Y., Wang, X., Wang, X., Zhang, F., Kwan, J. S. H., Chan, O. L. H., Wang, Z., Ungvari, G. S., et al. (2015) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000358 · Cited by 13
Association between altered physical activity and neurocognitive function among people with schizophrenia: A minimum 6-months' follow-up study
Kurebayashi, Y., & Otaki, J. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.06.001 · Cited by 13
Insight and Associated Factors among Patients with Schizophrenia in Mental Specialized Hospital, Ethiopia, 2018
Tariku, M., Demilew, D., Fanta, T., Mekonnen, M., & Angaw, D. A. (2019) · Psychiatry Journal · doi:10.1155/2019/2453862 · Cited by 14
Estimating the minimum important difference for the questionnaire about the Process of Recovery (QPR): an anchor-based approach
Dehmahdi, N., Law, H., Pyle, M., Byrne, R. E., Jones, W., Peel, H., & Morrison, A. P. (2021) · Psychosis · doi:10.1080/17522439.2021.1883726 · Cited by 13
Cognitive remediation for older community‐dwelling individuals with schizophrenia: a pilot and feasibility study
Golas, A., Kalache, S. M., Tsoutsoulas, C., Mulsant, B. H., Bowie, C. R., & Rajji, T. K. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4329 · Cited by 13
Binge drinking: Prevalence, correlates, and expectancies of alcohol use among individuals with first‐episode psychosis
Tan, J. H., Shahwan, S., Satghare, P., Cetty, L., Verma, S. K., Sendren, J. R., Chong, S. A., & Subramaniam, M. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12744 · Cited by 13
Aggressive Behavior in Schizophrenia: Relationship to Age of Onset and Cortical Atrophy
Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459308994254 · Cited by 13
Toll-Like Receptor 4 Gene Polymorphisms and Susceptibility to Schizophrenia: A Case-Control Study
Mostafa, M., Elwasify, M., Fathy, A. A., & Abdelsalam, M. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2093118 · Cited by 12
Declarative memory and WCST-64 performance in subjects with schizophrenia and healthy controls
Egan, G. J., Hasenkamp, W. M., Wilcox, L., Green, A. M., Hsu, N. H., Boshoven, W., Lewison, B., Keyes, M. D., & Duncan, E. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.02.026 · Cited by 13
Conformance to schizophrenia treatment guidelines in North West-Bank, Palestine: focus on antipsychotic dosing and polytherapy
Sweileh, W. M., Odeh, J. B., Zyoud, S. H., Sawalha, A. F., & Ihbeasheh, M. S. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-179 · Cited by 12
Rapid detection of alteration of serum IgG in patients with schizophrenia after risperidone treatment by matrix‐assisted laser desorption ionization/time‐of‐flight mass spectrometry
Lo, L., Shiea, J., & Huang, T. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7753 · Cited by 12
Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression
Schennach, R., Obermeier, M., Spellmann, I., Seemüller, F., Musil, R., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.022 · Cited by 12
The association between BDNF C270T genetic variants and smoking in patients with mental disorders and in healthy controls
Pivac, N., Erjavec, G. N., Šagud, M., Perković, M. N., Tudor, L., Uzun, S., Petrović, Z. K., Konjevod, M., Dvojkovic, A., Kozumplik, O., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110452 · Cited by 11
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies
Spellmann, I., Schennach, R., Seemüller, F., Meyer, S., Musil, R., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0741-2 · Cited by 12
Developing a dynamic model of anomalous experiences and function in young people with or without psychosis: a cross-sectional and longitudinal study protocol
Wright, A. C., Fowler, D. G., & Greenwood, K. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022546 · Cited by 14
Investigation of sex differences in delusion-associated cognitive biases
de Vos, C., Leanza, L., Mackintosh, A., Lüdtke, T., Balzan, R. P., Moritz, S., & Andreou, C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.121 · Cited by 11

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks